Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.68M$1.68Mderived+2.7% vs Q4 2016 Net Income-$2.08M-$2.08MderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,832,598N/M Operating Cash Flowderived-$1,745,730N/M Free Cash Flowderived-$1,747,967N/M Margins · derivedOperating margin-109.1%+0.4 pt vs Q4 2016
Net margin-124.0%−21.2 pt vs Q4 2016
ended Dec 31, 2017 · filed Mar 21, 2018 · 80 d after period end